Ventral tegmental area dopamine and GABA neurons: Physiological properties and expression of mRNA for endocannabinoid biosynthetic elements

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Merrill, Collin B ^a   Friend, Lindsey N ^a   Newton, Scott T ^a   Hopkins, Zachary H ^a   Edwards, Jeffrey G ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALCIUM BINDING PROTEIN; CALCIUM-BINDING PROTEIN (BRAIN); DOPAMINE; ENDOCANNABINOID; MESSENGER RNA; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; METABOTROPIC RECEPTOR; NEUROPEPTIDE; TRANSCRIPTOME;

ANIMAL; BIOSYNTHESIS; ELECTROPHYSIOLOGY; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOUSE; NERVE CELL PLASTICITY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE; VENTRAL TEGMENTUM;

ANIMALS; CALCIUM-BINDING PROTEINS; DOPAMINE; ELECTROPHYSIOLOGICAL PHENOMENA; ENDOCANNABINOIDS; GABAERGIC NEURONS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, TRANSGENIC; NEURONAL PLASTICITY; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RNA, MESSENGER; TRANSCRIPTOME; VENTRAL TEGMENTAL AREA;

EID: 84946761364     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16176     Document Type: Article

References (89)

1. Fields, H. L., Hjelmstad, G. O., Margolis, E. B. & Nicola, S. M. Ventral Tegmental Area Neurons in Learned Appetitive Behavior and Positive Reinforcement. Annu. Rev. Neurosci. 30, 289-316, doi: doi: 10.1146/annurev.neuro.30.051606-094341 (2007).
2. Mathon, D. S., Ramakers, G. M., Pintar, J. E. & Marinelli, M. Decreased firing frequency of midbrain dopamine neurons in mice lacking mu opioid receptors. Eur. J. Neurosci. 21, 2883-2886, doi: 10.1111/j.1460-9568.2005.04123.x (2005).
3. van Zessen, R., Phillips, J. L., Budygin, E. A. & Stuber, G. D. Activation of VTA GABA neurons disrupts reward consumption. Neuron 73, 1184-1194, doi: 10.1016/j.neuron.2012.02.016 (2012).
4. Parker, J. G. et al. Attenuating GABA(A) receptor signaling in dopamine neurons selectively enhances reward learning and alters risk preference in mice. J. Neurosci. 31, 17103-17112, doi: 10.1523/JNEUROSCI.1715-11.2011 (2011).
5. Tan, K. R. et al. GABA neurons of the VTA drive conditioned place aversion. Neuron 73, 1173-1183, doi: 10.1016/j. neuron.2012.02.015 (2012).
6. Bocklisch, C. et al. Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area. Science 341, 1521-1525, doi: 10.1126/science.1237059 (2013).
7. Brown, M. T. et al. Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning. Nature 492, 452-456, doi: 10.1038/nature11657 (2012).
8. Mathon, D. S. et al. Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice. Neuroscience 130, 359-367, doi: 10.1016/j.neuroscience.2004.10.002 (2005).
9. Hnasko, T. S., Hjelmstad, G. O., Fields, H. L. & Edwards, R. H. Ventral tegmental area glutamate neurons: electrophysiological properties and projections. J. Neurosci. 32, 15076-15085, doi: 10.1523/JNEUROSCI.3128-12.2012 (2012).
10. Kortleven, C., Fasano, C., Thibault, D., Lacaille, J. C. & Trudeau, L. E. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice. The European journal of neuroscience 33, 1751-1760, doi: 10.1111/j.1460-9568.2011.07648.x (2011).
11. Oleson, E. B. et al. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron 73, 360-373, doi: 10.1016/j.neuron.2011.11.018 (2012).
12. Pan, B., Hillard, C. J. & Liu, Q. S. Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. The Journal of neuroscience: the official journal of the Society for Neuroscience 28, 1385-1397, doi: 10.1523/ JNEUROSCI.4033-07.2008 (2008).
13. Perra, S. et al. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology 183, 368-377, doi: 10.1007/s00213-005-0195-0 (2005).
14. Matyas, F. et al. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 54, 95-107, doi: 10.1016/j.neuropharm.2007.05.028 (2008).
15. Matyas, F., Watanabe, M., Mackie, K., Katona, I. & Freund, T. F. Molecular architecture of the cannabinoid signaling system in the core of the nucleus accumbens. Ideggyogyaszati szemle 60, 187-191 (2007).
16. Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A. & Kano, M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31, 463-475 (2001).
17. Varma, N., Carlson, G. C., Ledent, C. & Alger, B. E. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J. Neurosci. 21, RC188 (2001).
18. Jung, K. M. et al. Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol. Pharmacol. 68, 1196-1202, doi: 10.1124/mol.105.013961 (2005).
19. Geisler, S., Derst, C., Veh, R. W. & Zahm, D. S. Glutamatergic afferents of the ventral tegmental area in the rat. J. Neurosci. 27, 5730-5743, doi: 10.1523/JNEUROSCI.0012-07.2007 (2007).
20. Merrill, C. B. et al. Identification of mRNA for endocannabinoid biosynthetic enzymes within hippocampal pyramidal cells and CA1 stratum radiatum interneuron subtypes using quantitative real-time polymerase chain reaction. Neuroscience 218, 89-99, doi: 10.1016/j.neuroscience.2012.05.012 (2012).
21. Cristino, L. et al. Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain. Neuroscience 151, 955-968 (2008).
22. Peterfi, Z. et al. Endocannabinoid-mediated long-term depression of afferent excitatory synapses in hippocampal pyramidal cells and GABAergic interneurons. J. Neurosci. 32, 14448-14463, doi: 10.1523/JNEUROSCI.1676-12.2012 (2012).
23. Gibson, H. E., Edwards, J. G., Page, R. S., Van Hook, M. J. & Kauer, J. A. TRPV1 Channels Mediate Long-Term Depression at Synapses on Hippocampal Interneurons. Neuron 57, 746-759 (2008).
24. Johnson, S. W. & North, R. A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. 450, 455-468 (1992).
25. Chieng, B., Azriel, Y., Mohammadi, S. & Christie, M. J. Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J. Physiol. 589, 3775-3787, doi: 10.1113/jphysiol.2011.210807 (2011).
26. Margolis, E. B., Lock, H., Hjelmstad, G. O. & Fields, H. L. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? The Journal of Physiology 577, 907-924, doi: 10.1113/jphysiol.2006.117069 (2006).
27. Margolis, E. B., Toy, B., Himmels, P., Morales, M. & Fields, H. L. Identification of rat ventral tegmental area GABAergic neurons. PLoS One 7, e42365, doi: 10.1371/journal.pone.0042365 (2012).
28. Tamamaki, N. et al. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. The Journal of Comparative Neurology 467, 60-79 (2003).
29. Tanimura, A. et al. The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic Transmission. Neuron 65, 320-327 (2010).
30. Hwang, S. W. et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. USA 97, 6155-6160, doi: 97/11/6155 [pii] (2000).
31. Di Marzo, V. et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691 (1994).
32. Ueda, N., Okamoto, Y. & Morishita, J. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: A novel enzyme of the β -lactamase fold family releasing anandamide and other N-acylethanolamines. Life Sci. 77, 1750-1758 (2005).
33. Kauer, J. A. Addictive drugs and stress trigger a common change at VTA synapses. Neuron 37, 549-550 (2003).
34. Borgland, S. L., Malenka, R. C. & Bonci, A. Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J. Neurosci. 24, 7482-7490, doi: 10.1523/ JNEUROSCI.1312-04.2004 (2004).
35. Saal, D., Dong, Y., Bonci, A. & Malenka, R. C. Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons. Neuron 37, 577-582 (2003).
36. Niehaus, J. L., Murali, M. & Kauer, J. A. Drugs of abuse and stress impair LTP at inhibitory synapses in the ventral tegmental area. Eur. J. Neurosci. 32, 108-117, doi: 10.1111/j.1460-9568.2010.07256.x (2010).
37. Dacher, M. & Nugent, F. S. Morphine-induced modulation of LTD at GABAergic synapses in the ventral tegmental area. Neuropharmacology 61, 1166-1171, doi: 10.1016/j.neuropharm.2010.11.012 (2011).
38. Melis, M. et al. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci. 24, 53-62, doi: 10.1523/JNEUROSCI.4503-03.2004 (2004).
39. Riegel, A. C. & Lupica, C. R. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J. Neurosci. 24, 11070-11078, doi: 10.1523/JNEUROSCI.3695-04.2004 (2004).
40. Michaeli, A. & Yaka, R. Dopamine-related drugs act presynaptically to potentiate GABA(A) receptor currents in VTA dopamine neurons. Neuropharmacology 61, 234-244, doi: 10.1016/j.neuropharm.2011.04.004 (2011).
41. Nugent, F. S. & Kauer, J. A. LTP of GABAergic synapses in the ventral tegmental area and beyond. J. Physiol. 586, 1487-1493, doi: 10.1113/jphysiol.2007.148098 (2008).
42. Lammel, S., Lim, B. K. & Malenka, R. C. Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 76 Pt B, 351-359, doi: 10.1016/j.neuropharm.2013.03.019 (2014).
43. Zhang, T. A., Placzek, A. N. & Dani, J. A. In vitro identification and electrophysiological characterization of dopamine neurons in the ventral tegmental area. Neuropharmacology 59, 431-436, doi: 10.1016/j.neuropharm.2010.06.004 (2010).
44. Stamatakis, A. M. et al. A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward. Neuron 80, 1039-1053, doi: 10.1016/j.neuron.2013.08.023 (2013).
45. Lammel, S. et al. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57, 760-773, doi: 10.1016/j.neuron.2008.01.022 (2008).
46. Korotkova, T. M., Sergeeva, O. A., Eriksson, K. S., Haas, H. L. & Brown, R. E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci. 23, 7-11 (2003).
47. Koyama, S., Kanemitsu, Y. & Weight, F. F. Spontaneous activity and properties of two types of principal neurons from the ventral tegmental area of rat. J. Neurophysiol. 93, 3282-3293, doi: 10.1152/jn.00776.2004 (2005).
48. Steffensen, S. C., Svingos, A. L., Pickel, V. M. & Henriksen, S. J. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J. Neurosci. 18, 8003-8015 (1998).
49. Olson, V. G. & Nestler, E. J. Topographical organization of GABAergic neurons within the ventral tegmental area of the rat. Synapse 61, 87-95, doi: 10.1002/syn.20345 (2007).
50. Gonzalez-Hernandez, T., Barroso-Chinea, P., Acevedo, A., Salido, E. & Rodriguez, M. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons. Eur. J. Neurosci. 13, 57-67 (2001).
51. Ascoli, G. A. et al. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nature Reviews Neuroscience 9, 557-568, doi: 10.1038/nrn2402 (2008).
52. Rajakumar, N., Elisevich, K. & Flumerfelt, B. A. Parvalbumin-containing GABAergic neurons in the basal ganglia output system of the rat. J. Comp. Neurol. 350, 324-336, doi: 10.1002/cne.903500214 (1994).
53. Korotkova, T. M., Ponomarenko, A. A., Brown, R. E. & Haas, H. L. Functional diversity of ventral midbrain dopamine and GABAergic neurons. Mol. Neurobiol. 29, 243-259, doi: 10.1385/MN:29:3:243 (2004).
54. Wierenga, C. J. et al. Molecular and electrophysiological characterization of GFP-expressing CA1 interneurons in GAD65-GFP mice. PLoS One 5, e15915, doi: 10.1371/journal.pone.0015915 (2010).
55. Isaacs, K. R. & Jacobowitz, D. M. Mapping of the colocalization of calretinin and tyrosine hydroxylase in the rat substantia nigra and ventral tegmental area. Exp. Brain Res. 99, 34-42 (1994).
56. Freund, T. F. & Buzsáki, G. Interneurons of the hippocampus. Hippocampus 6, 347-470 (1996).
57. Rogers, J. H. Immunohistochemical markers in rat brain: colocalization of calretinin and calbindin-D28k with tyrosine hydroxylase. Brain Res. 587, 203-210 (1992).
58. Hokfelt, T. et al. Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature 285, 476-478 (1980).
59. Seroogy, K. et al. Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/ monoamine coexistence studies using in situ hybridization combined with immunocytochemistry. Exp. Brain Res. 74, 149-162 (1989).
60. Nemoto, C., Hida, T. & Arai, R. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study. Brain Res. 846, 129-136 (1999).
61. Lafourcade, M. et al. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS One 2, e709, doi: 10.1371/journal.pone.0000709 (2007).
62. Suarez, J. et al. Distribution of diacylglycerol lipase alpha, an endocannabinoid synthesizing enzyme, in the rat forebrain. Neuroscience 192, 112-131, doi: 10.1016/j.neuroscience.2011.06.062 (2011).
63. Katona, I. et al. Molecular composition of the endocannabinoid system at glutamatergic synapses. The Journal of neuroscience 26, 5628-5637, doi: 10.1523/JNEUROSCI.0309-06.2006 (2006).
64. Melis, M. et al. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci. 24, 10707-10715, doi: 10.1523/JNEUROSCI.3502-04.2004 (2004).
65. Robinson, S. A., Loiacono, R. E., Christopoulos, A., Sexton, P. M. & Malone, D. T. The effect of social isolation on rat brain expression of genes associated with endocannabinoid signaling. Brain Res. 1343, 153-167, doi: 10.1016/j.brainres.2010.04.031 (2010).
66. Pillolla, G. et al. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo. Psychopharmacology 191, 843-853, doi: 10.1007/s00213-007-0733-z (2007).
67. Luchicchi, A. et al. Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. Addict. Biol. 15, 277-288, doi: 10.1111/j.1369-1600.2010.00222.x (2010).
68. Manzoni, O. J. & Williams, J. T. Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J. Neurosci. 19, 6629-6636 (1999).
69. Walters, C. L. et al. Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption. Psychopharmacology (Berl.) 170, 124-131, doi: 10.1007/s00213-003-1526-7 (2003).
70. Edwards, J. G. TRPV1 in the central nervous system: synaptic plasticity, function, and pharmacological implications. Prog. Drug Res. 68, 77-104 (2014).
71. Marinelli, S., Pascucci, T., Bernardi, G., Puglisi-Allegra, S. & Mercuri, N. Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology 30, 864-870 (2005).
72. Marinelli, S. et al. N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology 32, 298-308, doi: 10.1038/sj.npp.1301118 (2007).
73. Nguyen, T. L. et al. Transient receptor potential vanilloid type 1 channel may modulate opioid reward. Neuropsychopharmacology 39, 2414-2422, doi: 10.1038/npp.2014.90 (2014).
74. Testa, C. M., Standaert, D. G., Young, A. B. & Penney, J. B. Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci. 14, 3005-3018 (1994).
75. Bellone, C. & Luscher, C. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat. Neurosci. 9, 636-641, doi: 10.1038/nn1682 (2006).
76. Bellone, C. & Luscher, C. mGluRs induce a long-term depression in the ventral tegmental area that involves a switch of the subunit composition of AMPA receptors. Eur. J. Neurosci. 21, 1280-1288, doi: 10.1111/j.1460-9568.2005.03979.x (2005).
77. Mameli, M., Balland, B., Lujan, R. & Luscher, C. Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area. Science 317, 530-533, doi: 10.1126/science.1142365 (2007).
78. Chau, P., Soderpalm, B. & Ericson, M. The mGluR5 antagonist MPEP elevates accumbal dopamine and glycine levels; interaction with strychnine-sensitive glycine receptors. Addict. Biol. 16, 591-599, doi: 10.1111/j.1369-1600.2011.00343.x (2011).
79. Romano, C. et al. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. The Journal of Comparative Neurology 355, 455-469, doi: 10.1002/cne.903550310 (1995).
80. Tronci, V. & Balfour, D. J. The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain. Behav. Brain Res. 219, 354-357, doi: 10.1016/j.bbr.2010.12.024 (2011).
81. Chiamulera, C. et al. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat. Neurosci. 4, 873-874, doi: 10.1038/nn0901-873 (2001).
82. Bird, M. K. et al. Cocaine-mediated synaptic potentiation is absent in VTA neurons from mGlu5-deficient mice. Int. J. Neuropsychopharmacol. 13, 133-141, doi: 10.1017/S1461145709990162 (2010).
83. Ghasemzadeh, M. B. et al. Glutamatergic plasticity in medial prefrontal cortex and ventral tegmental area following extendedaccess cocaine self-administration. Brain Res. 1413, 60-71, doi: 10.1016/j.brainres.2011.06.041 (2011).
84. Timmer, K. M. & Steketee, J. D. Examination of a role for metabotropic glutamate receptor 5 in the medial prefrontal cortex in cocaine sensitization in rats. Psychopharmacology (Berl.) 221, 91-100, doi: 10.1007/s00213-011-2548-1 (2012).
85. Sudweeks, S. N., Hooft, J. A. & Yakel, J. L. Serotonin 5-HT(3) receptors in rat CA1 hippocampal interneurons: functional and molecular characterization. J. Physiol. 544, 715-726 (2002).
86. Seifert, G. et al. Analysis of astroglial K+ channel expression in the developing hippocampus reveals a predominant role of the Kir4.1 subunit. J. Neurosci. 29, 7474-7488, doi: 10.1523/JNEUROSCI.3790-08.2009 (2009).
87. Schroder, W., Seifert, G., Huttmann, K., Hinterkeuser, S. & Steinhauser, C. AMPA receptor-mediated modulation of inward rectifier K+ channels in astrocytes of mouse hippocampus. Mol. Cell. Neurosci. 19, 447-458, doi: 10.1006/mcne.2001.1080 (2002).
88. Sudweeks, S. N. & Yakel, J. L. Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J. Physiol. 527 Pt 3, 515-528 (2000).
89. Livak, K. J. & Schmittgen, T. D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-δ δ CT Method. Methods 25, 402-408 (2001).